Search General Info
Search Education
Search Partnering Companies

Wankyu Kim

Seoul, Korea, Republic of
Wankyu Kim, PhD is an expert in bioinformatics and in silico systems biology. He is a professor in Life Science, Ewha Womans Univ. since 2009 and a CEO of KaiPharm, a venture company for AI-driven drug discovery founded in Nov. 2018 together with his colleagues. Prior to current position, he received B.S./M.S. at the Department of Microbiology in Seoul National University in Korea, and PhD in Bioinformatics at the University of Cambridge, UK. Then, he was trained as post-doc at Edward Marcotte’s lab of Univ. of Texas, Austin.
His recent work is focused on the subject of ‘in silico systems pharmacology’ or ‘Data-Driven Drug Discovery’ for developing analytic tools and algorithms for early-stage drug discovery. In particular, he first proposed a novel idea of ‘Assay Repositioning’ i.e. reuse of compound screening dataset in virtual screening for the targets different from their original purposes, and has a broad experience in large-scale mining of drug-induced transcriptome data (CMAP).
Speaking In
[Available On-Demand]
KaiPharm is an AI-Data-driven drug discovery company located in Seoul, Korea. Our technology…